Efficacy and safety of subcutaneous interferon-β-1a in patients with a first demyelinating event and early multiple sclerosis. Freedman MS Expert Opin Biol Ther. 2014 Aug; 14(8):1207-14. Epub 2014 Jun 26. PMID: 24965353. Abstract CommentRecommendBookmarkWatch